Ventyx Biosciences, Inc. (NASDAQ: VTYX) reported Q4 EPS of ($0.62), $0.03 worse than the analyst estimate of ($0.59).

For earnings history and earnings-related data on Ventyx Biosciences, Inc. (VTYX) click here.